BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30662920)

  • 1. TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients.
    Nezos A; Gkioka E; Koutsilieris M; Voulgarelis M; Tzioufas AG; Mavragani CP
    J Immunol Res; 2018; 2018():6923213. PubMed ID: 30662920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphoma.
    Nocturne G; Tarn J; Boudaoud S; Locke J; Miceli-Richard C; Hachulla E; Dubost JJ; Bowman S; Gottenberg JE; Criswell LA; Lessard CJ; Sivils KL; Carapito R; Bahram S; Seror R; Ng WF; Mariette X
    Ann Rheum Dis; 2016 Apr; 75(4):780-3. PubMed ID: 26338037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.
    Papageorgiou A; Mavragani CP; Nezos A; Zintzaras E; Quartuccio L; De Vita S; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    Arthritis Rheumatol; 2015 Oct; 67(10):2732-41. PubMed ID: 26097183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients.
    Ciccacci C; Latini A; Perricone C; Conigliaro P; Colafrancesco S; Ceccarelli F; Priori R; Conti F; Perricone R; Novelli G; Borgiani P
    J Immunol Res; 2019; 2019():6728694. PubMed ID: 31534975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A failure of TNFAIP3 negative regulation maintains sustained NF-κB activation in Sjögren's syndrome.
    Sisto M; Lisi S; Lofrumento DD; Ingravallo G; Maiorano E; D'Amore M
    Histochem Cell Biol; 2011 Jun; 135(6):615-25. PubMed ID: 21604024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome.
    Nocturne G; Boudaoud S; Miceli-Richard C; Viengchareun S; Lazure T; Nititham J; Taylor KE; Ma A; Busato F; Melki J; Lessard CJ; Sivils KL; Dubost JJ; Hachulla E; Gottenberg JE; Lombès M; Tost J; Criswell LA; Mariette X
    Blood; 2013 Dec; 122(25):4068-76. PubMed ID: 24159176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
    Sisto M; Barca A; Lofrumento DD; Lisi S
    Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome.
    Nordmark G; Wang C; Vasaitis L; Eriksson P; Theander E; Kvarnström M; Forsblad-d'Elia H; Jazebi H; Sjöwall C; Reksten TR; Brun JG; Jonsson MV; Johnsen SJ; Wahren-Herlenius M; Omdal R; Jonsson R; Bowman S; Ng WF; Eloranta ML; Syvänen AC;
    Scand J Immunol; 2013 Nov; 78(5):447-54. PubMed ID: 23944604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional variants of TNFAIP3 are associated with systemic lupus erythematosus in a cohort of Chinese Han population.
    Xu M; Gao W; Wu L; Liu X; Yu D; Shi X; Liu X; Wang Q; Fu X; Yu J; Xu B; Wang S
    Hum Immunol; 2019 Feb; 80(2):140-145. PubMed ID: 30529365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Protein A20 in Minor Salivary Glands is Associated with Lymphoma in Primary Sjögren's Syndrome.
    Johnsen SJ; Gudlaugsson E; Skaland I; Janssen EA; Jonsson MV; Helgeland L; Berget E; Jonsson R; Omdal R
    Scand J Immunol; 2016 Mar; 83(3):181-7. PubMed ID: 26679293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
    Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
    J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREX1 variants in Sjogren's syndrome related lymphomagenesis.
    Nezos A; Makri P; Gandolfo S; De Vita S; Voulgarelis M; Crow MK; Mavragani CP
    Cytokine; 2020 Aug; 132():154781. PubMed ID: 31326279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk.
    Kim T; Bae SC; Kang C
    Arthritis Res Ther; 2020 Apr; 22(1):93. PubMed ID: 32334614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren's Syndrome.
    Argyriou E; Nezos A; Roussos P; Venetsanopoulou A; Voulgarelis M; Boki K; Tzioufas AG; Moutsopoulos HM; Mavragani CP
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33567548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the cytoplasmic ubiquitin ligase TNFAIP3 gene variation on transcription factor NF-κB activation in acute kidney injury.
    Rogers NM; Zammit N; Nguyen-Ngo D; Souilmi Y; Minhas N; Meijles DN; Self E; Walters SN; Warren J; Cultrone D; El-Rashid M; Li J; Chtanova T; O'Connell PJ; Grey ST
    Kidney Int; 2023 Jun; 103(6):1105-1119. PubMed ID: 37097268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association studies of TNFSF4, TNFAIP3 and FAM167A-BLK polymorphisms with primary Sjogren's syndrome in Han Chinese.
    Sun F; Li P; Chen H; Wu Z; Xu J; Shen M; Leng X; Shi Q; Zhang W; Tian X; Li Y; Zhang F
    J Hum Genet; 2013 Jul; 58(7):475-9. PubMed ID: 23635951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered IκBα expression promotes NF-κB activation in monocytes from primary Sjögren's syndrome patients.
    Lisi S; Sisto M; Lofrumento DD; D'Amore M
    Pathology; 2012 Oct; 44(6):557-61. PubMed ID: 22935973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Xinfeng Capsule reduces hypercoagulative state in patients with Sjogren's syndrome by inhibiting miR-155/SOCS1/NF-κB signaling pathway].
    Zhu F; Liu J; Wang G; Fang L; Zhang P; Tan B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1366-1371. PubMed ID: 27667464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes.
    Mavragani CP; Nezos A; Sagalovskiy I; Seshan S; Kirou KA; Crow MK
    J Autoimmun; 2018 Mar; 88():75-82. PubMed ID: 29074164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of dendritic cell immunoreceptor (DCIR) polymorphisms in susceptibility of systemic lupus erythematosus and primary Sjogren's syndrome.
    Liu M; Wu X; Liu X; He J; Su Y; Guo J; Li Z
    Hum Immunol; 2015 Nov; 76(11):808-11. PubMed ID: 26429306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.